Vilgelm Laboratory

Translational Oncology Research

MDM2 Antagonists Counteract Drug-Induced DNA Damage


Journal article


A. Vilgelm, Priscilla Escalante Cobb, Kiran Malikayil, D. Flaherty, C. Andrew Johnson, D. Raman, Nabil Saleh, B. Higgins, Brandon A Vara, J. N. Johnston, Douglas B. Johnson, M. Kelley, Sheau-Chiann Chen, G. Ayers, A. Richmond
EBioMedicine, 2017

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Vilgelm, A., Cobb, P. E., Malikayil, K., Flaherty, D., Johnson, C. A., Raman, D., … Richmond, A. (2017). MDM2 Antagonists Counteract Drug-Induced DNA Damage. EBioMedicine.


Chicago/Turabian   Click to copy
Vilgelm, A., Priscilla Escalante Cobb, Kiran Malikayil, D. Flaherty, C. Andrew Johnson, D. Raman, Nabil Saleh, et al. “MDM2 Antagonists Counteract Drug-Induced DNA Damage.” EBioMedicine (2017).


MLA   Click to copy
Vilgelm, A., et al. “MDM2 Antagonists Counteract Drug-Induced DNA Damage.” EBioMedicine, 2017.


BibTeX   Click to copy

@article{a2017a,
  title = {MDM2 Antagonists Counteract Drug-Induced DNA Damage},
  year = {2017},
  journal = {EBioMedicine},
  author = {Vilgelm, A. and Cobb, Priscilla Escalante and Malikayil, Kiran and Flaherty, D. and Johnson, C. Andrew and Raman, D. and Saleh, Nabil and Higgins, B. and Vara, Brandon A and Johnston, J. N. and Johnson, Douglas B. and Kelley, M. and Chen, Sheau-Chiann and Ayers, G. and Richmond, A.}
}